about
Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetesImmunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetesPersistent infection of a carcinoma thyroid cell line with coxsackievirus B.Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine.New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factorImmunoglobulin G-dependent enhancement of the infection with Coxsackievirus B4 in a murine system.Enteroviruses and type 1 diabetes: towards a better understanding of the relationship.Enteroviral pathogenesis of type 1 diabetes.Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.Enteroviruses in blood of patients with type 1 diabetes detected by integrated cell culture and reverse transcription quantitative real-time PCR.Resistance of Enteric Viruses on Fomites.Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates.Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice Stools.Marker of coxsackievirus-B4 infection in saliva of patients with type 1 diabetes.Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro.Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.In-utero coxsackievirus B4 infection of the mouse thymus.Exposure of Piglets to Enteroviruses Investigated by an Immunoassay Based on the EV-G1 VP4 Peptide.Central nervous system infection following vertical transmission of Coxsackievirus B4 in mice.Antibodies to VP1 of swine pasivirus in humans without evidence of transmission from a pig source.High Efficiency of Functional Carbon Nanodots as Entry Inhibitors of Herpes Simplex Virus Type 1.Coxsackievirus B4 Can Infect Human Peripheral Blood-Derived MacrophagesSurvival of Enveloped and Non-Enveloped Viruses on Inanimate SurfacesSynergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cellsAntiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins.Viruses contained in droplets applied on warmed surface are rapidly inactivated.Higher levels of hepatitis C virus RNA found in blood donors co-infected with HIV as compared to HCV mono-infected donors.Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells.Detection of hepatitis B virus infection markers in dried plasma spots among patients in Congo-Brazzaville.Specificity of the coxsackievirus B4 VP4 capsid protein investigated in silico.[Acute polyarthritis during a parvovirus B19 primary infection]Cervical samples dried on filter paper and dried vaginal tampons can be useful to investigate the circulation of high-risk HPV in Congo.Inhibition of coxsackievirus B4 by Lactobacillus plantarum.Aqueous extracts of Syzygium brazzavillense can inhibit the infection with coxsackievirus B4 in vitroHuman milk can neutralize Coxsackievirus B4 in vitro[Simultaneous detection of IgM anti-Epstein-Barr virus and IgM anti-hepatitis A during an acute hepatitis][When an enterovirus emerges]
P50
Q27008445-04FF0AB6-1B08-44D9-ABAE-4C964AAF6834Q27011799-9F8047F1-9669-4EA4-B624-68ACFB7BCE84Q33418888-075C490E-EA73-4B7C-8E98-E9D134C7A974Q34043114-3E9AA2A5-18E8-483F-838F-E50D34B984FEQ35914270-0749A1D6-2ADB-4F11-8250-4E4013C0D6B1Q36276241-11B7EF59-D337-40C0-AA23-446001827A3BQ37262868-E1332EFD-F561-4758-96BF-A26F790748BCQ37772438-46EEE4C0-2D16-43C1-A0DF-88BA356EE0E6Q37784271-330731DF-425D-402D-AFD6-AE3780ACAA18Q37877267-001A5CAB-4C4E-4417-B456-ACB8962595D6Q38693613-CD7940AC-315D-472C-82E3-544DE0B10B30Q38725613-DB61D786-F65B-43D2-AD73-A830BAA36192Q38732011-C49C326A-6064-4CDA-A02B-EC1F36FE3CCFQ39138391-7892F733-486E-4F95-887C-0BB77584697FQ39238492-7FC6F1A0-B393-4003-98E6-174306542629Q40063941-ECDC2DDE-488D-4483-8ED1-233C7ACC1A62Q40118654-D3C6C0FC-3111-4936-94A8-88F03CBC83CCQ40166957-0F7488CB-33CF-4CE8-A9B5-ED2CBD5E4E31Q40361991-208E22E1-44AD-410D-9454-F894775EB68AQ40478350-895D2509-DE09-488A-B153-986ECEE72DD5Q40519596-6A95F8EC-E807-45A1-AEFF-CBEEE3954388Q40531437-2FE15C9C-095F-46BA-96EB-CE01E33C4778Q40698192-C15C03AE-1B62-4D8E-BA51-15E5314BCBE4Q40740639-93DD14B2-7E85-4076-8785-2CCFA819F753Q40893867-FEB72576-6CE0-450A-950A-126ED39EFFD5Q41354809-20541754-05DC-4874-A97A-8D7C05408FD4Q41399147-B0AA0B8A-6F58-4C51-9690-C4A70CBC3938Q41930599-E0FE72F5-3487-4349-B950-985150BE8A6FQ42087630-EAED4F91-346C-4C02-AB1B-A34C9A915C7AQ42200424-9BFE9F47-30C8-4129-9BA7-91671EE12955Q42244449-F41ED47A-447E-462E-B0F2-DB0B6F5DCC1FQ42248756-D5ABF90F-F9CA-4999-B932-58B700078253Q43821130-EF119474-C489-4C59-A244-80F2E264B453Q45040660-724BACFF-19BA-4496-A28E-52352387B265Q46484641-169AA0CB-026C-42A7-8622-B570DAC69F48Q54240361-1F2806A6-28E9-40BD-88BF-483A17533B0FQ64360304-C8F27591-562C-4E1F-9DA6-02180FFABEDEQ64361942-1C88D9D5-D4FD-46A5-B62F-F4890BC4BAD0Q79240034-E9911A25-1B89-49AC-B98C-F3FE3D0B70F5Q83263005-9AD0DC09-006E-4796-97D7-41FF5FC261B9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Famara Sane
@ast
Famara Sane
@en
Famara Sane
@es
Famara Sane
@nl
Famara Sane
@sl
type
label
Famara Sane
@ast
Famara Sane
@en
Famara Sane
@es
Famara Sane
@nl
Famara Sane
@sl
prefLabel
Famara Sane
@ast
Famara Sane
@en
Famara Sane
@es
Famara Sane
@nl
Famara Sane
@sl
P108
P106
P108
P1153
24779121600
P31
P496
0000-0003-1972-9312